A single-center study of thoracoscopic surgery in the treatment of pediatric mediastinal neurogenic tumors
- PMID: 36351570
- PMCID: PMC9807445
- DOI: 10.1111/1759-7714.14708
A single-center study of thoracoscopic surgery in the treatment of pediatric mediastinal neurogenic tumors
Abstract
Objective: To study the feasibility, safety, and efficacy of thoracoscopic surgery in the treatment of pediatric mediastinal neurogenic tumors, and summarize the treatment experiences and surgical skills.
Methods: A single-center retrospective analysis of 37 patients with pediatric mediastinal neurogenic tumors was conducted. Clinical charactersistics and postoperative complications were all analyzed.
Results: All the operations were successfully completed. There was no statistically significant difference in tumor diameter between the two groups (p > 0.05). The open surgery group had an average operation time of 96.5 ± 32.38 min, while the thoracoscopic surgery group had an average operation time of 78.3 ± 24.51 min (p < 0.05). The thoracoscopic surgery group had significantly lower intraoperative blood loss than the open surgery group (p < 0.05). In addition, the duration of the postoperative thoracic drainage tube was 5.43 ± 0.76 days in the open surgery group, which was longer than the 2.38 ± 0.87 days in the thoracoscopic surgery group (p < 0.05). Furthermore, the postoperative length of hospital stay was an average of 10.23 ± 1.43 days for the open surgery group, longer than for the thoracoscopic surgery group (4.36 ± 0.87 days) (p < 0.05).
Conclusions: Thoracoscopic surgery has several advantages in the treatment of pediatric mediastinal neurogenic tumors and is worthy of clinical popularization and application. For giant mediastinal malignant neurogenic tumors, puncture biopsy and adjuvant chemotherapy can be performed before surgery to lessen the tumor volume and enlarge the operation space, which would reduce bleeding and complications.
Keywords: children neurogenic tumor; mediastinal neurogenic tumors; thoracoscope.
© 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Rodriguez EF, Jones R, Miller D, Rodriguez FJ. Neurogenic tumors of the mediastinum. Semin Diagn Pathol. 2020;37(4):179–86. - PubMed
-
- Bondar IV, Lebedev VI, Pashkov IV, et al. Klinicheskie proiavleniia i diagnostika opukholeĭ sredosteniia v detskom vozraste [Clinical manifestations and diagnosis of childhood mediastinal tumors]. Vestn Ross Akad Med Nauk. 2000;(6):3–5. Russian. - PubMed
-
- Mlika M, Marghli A, Souilem I, et al. A single‐institution experience of neurogenic tumors of the mediastinum. Asian Cardiovasc Thorac Ann. 2019;27(8):661–9. - PubMed
-
- Gaubert JY, Cohen F, Vidal V, et al. Imagerie des tumeurs du médiastin [Imaging of mediastinal tumors]. Rev Pneumol Clin. 2010;66(1):17–27. French. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
